These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 9031802)

  • 1. Remission of localized cutaneous leishmaniasis in a HIV-positive patient using systemic terbinafine.
    González-Rupérez J; Javaloyas de Morlius M; Moreno Carazo A
    Dermatology; 1997; 194(1):85-6. PubMed ID: 9031802
    [No Abstract]   [Full Text] [Related]  

  • 2. Failure of a combination of two antifungal drugs, terbinafine plus itraconazole, in Sudanese post kala-azar dermal leishmaniasis.
    Khalil EA; Nur NM; Zijlstra EE; El-Hassan AM; Davidson RN
    Trans R Soc Trop Med Hyg; 1996; 90(2):187-8. PubMed ID: 8761586
    [No Abstract]   [Full Text] [Related]  

  • 3. Terbinafine in the treatment of cutaneous leishmaniasis: a pilot study.
    Bahamdan KA; Tallab TM; Johargi H; Nourad MM; Ibrahim K; el Sherbini AH; Karkashan E; Khare AK; Nauri MM
    Int J Dermatol; 1997 Jan; 36(1):59-60. PubMed ID: 9071621
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dermacase: tinea incoanita.
    Nasseri E; Hammadi AA
    Can Fam Physician; 2007 Dec; 53(12):2113, 2123. PubMed ID: 18077744
    [No Abstract]   [Full Text] [Related]  

  • 5. Cutaneous leishmaniasis: an atypical case.
    Martinelli C; Giorgini S; Minu MB; Orsi A; Leoncini F
    Int J Dermatol; 2005 Jan; 44(1):38-40. PubMed ID: 15663657
    [No Abstract]   [Full Text] [Related]  

  • 6. Costs of pulse versus continuous terbinafine for onychomycosis.
    Schram SE; Warshaw EM
    J Am Acad Dermatol; 2007 Mar; 56(3):525-7. PubMed ID: 17317500
    [No Abstract]   [Full Text] [Related]  

  • 7. Successful treatment of cutaneous leishmaniasis of the ear with oral fluconazole.
    Veraldi S; Nazzaro G
    Clin Exp Dermatol; 2016 Apr; 41(3):315-6. PubMed ID: 26204912
    [No Abstract]   [Full Text] [Related]  

  • 8. An HIV-positive man with tattoo induration.
    López-Medrano F; Costa JR; Rodriguez-Peralto JL; Aguado JM
    Clin Infect Dis; 2007 Jul; 45(2):220-1, 267-8. PubMed ID: 17578782
    [No Abstract]   [Full Text] [Related]  

  • 9. Topical treatment for cutaneous leishmaniasis.
    Garnier T; Croft SL
    Curr Opin Investig Drugs; 2002 Apr; 3(4):538-44. PubMed ID: 12090720
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Terbinafine: broad new spectrum of indications in several subcutaneous and systemic and parasitic diseases.
    Pérez A
    Mycoses; 1999; 42 Suppl 2():111-4. PubMed ID: 10865916
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Old World leishmaniasis on the ear lobe: a rare site.
    Blasco Morente G; Rodríguez-Granger J; Tercedor Sánchez J; Latorre Fuentes JM
    Actas Dermosifiliogr; 2014; 105(6):628-30. PubMed ID: 24360726
    [No Abstract]   [Full Text] [Related]  

  • 12. Cutaneous leishmaniasis associated with visceral leishmaniasis in a case of acquired immunodeficiency syndrome (AIDS).
    Pourahmad M; Hooshmand F; Rahiminejad M
    Int J Dermatol; 2009 Jan; 48(1):59-61. PubMed ID: 19126052
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Post-Kala-Azar dermal leishmaniasis in an HIV-1-infected woman: recovery after amphotericin B following failure of oral miltefosine.
    Guffanti M; Gaiera G; Bossolasco S; Ceserani N; Ratti D; Cinque P; Salmaso F; Gianotti N; Lazzarin A
    Am J Trop Med Hyg; 2008 Nov; 79(5):715-8. PubMed ID: 18981510
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Leishmaniasis (PKDL) as a case of immune reconstitution inflammatory syndrome (IRIS) in HIV-positive patient after initiation of anti-retroviral therapy (ART).
    Tadesse A; Hurissa Z
    Ethiop Med J; 2009 Jan; 47(1):77-9. PubMed ID: 19743785
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Metronidazole treatment in a patient with AIDS and visceral leishmaniasis.
    Arranz-Caso JA; Albarrán-Hernández F; Cuadrado-Gómez LM; Gonzalez-Palacios R
    AIDS; 1995 Dec; 9(12):1377-8. PubMed ID: 8605059
    [No Abstract]   [Full Text] [Related]  

  • 16. [Mucocutaneous leishmaniasis in a HIV infected patient. Case report].
    Montenegro-Idrogo JJ; Montañez-Valverde RA; Chian C; Benites-Villafane C
    Rev Chilena Infectol; 2014 Oct; 31(5):610-4. PubMed ID: 25491462
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A 2-year study of liquid nitrogen therapy in cutaneous leishmaniasis.
    al-Majali O; Routh HB; Abuloham O; Bhowmik KR; Muhsen M; Hebeheba H
    Int J Dermatol; 1997 Jun; 36(6):460-2. PubMed ID: 9248896
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Safety and efficacy of short-duration oral terbinafine for the treatment of tinea corporis or tinea cruris in subjects with HIV infection or diabetes.
    Rich P; Houpt KR; LaMarca A; Loven KH; Marbury TC; Matheson R; Miller B; Smith S; Wolf J;
    Cutis; 2001 Jul; 68(1 Suppl):15-22. PubMed ID: 11499330
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The use of topical tartar emetic in cutaneous leishmaniasis].
    Romero GA; Vela JS; Marsden PD
    Rev Soc Bras Med Trop; 1996; 29(4):377. PubMed ID: 8768589
    [No Abstract]   [Full Text] [Related]  

  • 20. Pentamidine isethionate as treatment and secondary prophylaxis for disseminated cutaneous leishmaniasis during HIV infection: case report.
    Calza L; Marinacci G; Manfredi R; Colangeli V; Fortunato L; Chiodo F
    J Chemother; 2001 Dec; 13(6):653-7. PubMed ID: 11806628
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.